Derakhshan Behrad
SEC CIK 1853109 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | Chief Business Off | 36.9K | — | $2.05M | 16 | 2023-05-01 | 2026-08-12 |
Most active insiders at EWTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Russell Alan J | CSO, Dir | — | $10.25M |
| 2 | Donovan Joanne M. | CMO | — | $4.62M |
| 3 | Edris Badreddin | Dir | — | $3.40M |
| 4 | KOCH KEVIN | Pres, CEO, Dir | — | $785.0K |
| 5 | Derakhshan Behrad | Chief Business Off | — | $223.4K |
| 6 | MOORE JOHN R | GC | — | $219.8K |
| 7 | Fox Jonathan C | Dir | $199.4K | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-14 16:53 | 2026-08-12 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | M - OptEx | $0.00 | +13.3K | 36.9K | +56% | $0 |
| DM | 2026-08-14 16:53 | 2026-08-12 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | S - Sale+OE | $43.81 | -5,100 | 31.8K | -14% | -$223.4K |
| D | 2025-08-14 | 2025-08-12 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | S - Sale+OE | $13.39 | -2,491 | 23.6K | -10% | -$33.4K |
| D | 2025-08-14 | 2025-08-12 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | M - OptEx | $0.00 | +5,781 | 26.1K | +28% | $0 |
| D | 2025-05-07 | 2025-05-01 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | M - OptEx | $0.00 | +5,209 | 22.0K | +31% | $0 |
| D | 2025-05-07 | 2025-05-02 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | S - Sale+OE | $16.45 | -1,691 | 20.4K | -8% | -$27.8K |
| D | 2025-02-07 | 2025-02-05 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | M - OptEx | $1.93 | +10.0K | 26.8K | +59% | +$19.3K |
| D | 2025-02-07 | 2025-02-05 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | S - Sale+OE | $30.03 | -10.0K | 16.8K | -37% | -$300.3K |
| D | 2024-09-24 | 2024-09-20 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | M - OptEx | $1.93 | +42.1K | 57.2K | +278% | +$81.2K |
| D | 2024-09-24 | 2024-09-20 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | S - Sale+OE | $29.03 | -42.1K | 15.1K | -74% | -$1.22M |
| D | 2024-05-03 | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | S - Sale+OE | $18.91 | -1,718 | 13.4K | -11% | -$32.5K |
| D | 2024-05-03 | 2024-05-01 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | M - OptEx | $0.00 | +5,208 | 15.1K | +52% | $0 |
| DMT | 2024-02-09 | 2024-02-07+ | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | M - OptEx | $1.93 | +10.0K | 7,620 | New | +$19.3K |
| DMT | 2024-02-09 | 2024-02-07+ | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | S - Sale+OE | $20.02 | -10.0K | 7,020 | -59% | -$200.2K |
| D | 2023-05-03 | 2023-05-02 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | S - Sale+OE | $8.90 | -1,747 | 7,020 | -20% | -$15.5K |
| D | 2023-05-03 | 2023-05-01 | EWTX | Edgewise Therapeutics, Inc. | Derakhshan Behrad | Chief Business Off | M - OptEx | $0.00 | +5,208 | 8,767 | +146% | $0 |
Purchase Sale Sale after option exercise All abbreviations